AIM:To assess adherence rates to nucleos(t)ide analogues(NUCs) therapy in patients with chronic hepatitis B virus infection and determine factors associated wit
Chronic hepatitis C infection is the leading cause ofchronic liver disease, cirrhosis, hepatocellular carcinomaas well as the primary indication for livertransp